Pharmacologic treatments for covid-19 patients
Interferon beta-1b vs Interferon beta-1a
This comparison will not be updated. Last search date 14 Dec, 2022.
Hospitalized patients
Forest plots
(last update: 2021-03-05)
To access all information :
- click here for Hospitalized patients
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=280
Back to your research
Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
---|---|---|---|---|---|---|---|---|
Treatment 1 | Treatment 2 | |||||||
NCT04343768 COVIFERON Darazam IA, Scientific Reports, 2021 Full text Commentary Commentary |
No specific funding |
Interferon beta-1b Interferon beta-1a Interferon beta-1b Interferon beta-1b |
Standard care Standard care Interferon beta-1a Standard care |
RCT | Patients with confirmed COVID-19 (moderate-severe) admitted to a single center in Iran. | N=60 |
Some concerns Details |